Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1117Session 89R

What changed between versions

6 paragraphs changed+0 words added−46 removed

Highlighted text was added in the newer version. Struck-through text was removed.

By: Schwertner

S.B. No. 1117

(In the Senate - Filed February 5, 2025; February 24, 2025,

read first time and referred to Committee on Business & Commerce;

May 5, 2025, reported favorably by the following vote: Yeas 11,

Nays 0; May 5, 2025, sent to printer.)

Click here to see the committee vote

A BILL TO BE ENTITLED

15 unchanged paragraphs

AN ACT

relating to the administration of botulinum toxin by dentists.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter B, Chapter 258, Occupations Code, is

amended by adding Section 258.0531 to read as follows:

Sec. 258.0531. USE OF BOTULINUM TOXIN. (a) A dentist may,

for aesthetic purposes, administer to a patient's oral and

maxillofacial regions a neuromodulator containing botulinum toxin

or a biosimilar or bioequivalent neuromodulator only if the dentist

has completed a course of training approved by the board on the

administration of the neuromodulator.

(b) The board shall adopt rules to implement this section.

SECTION 2. Not later than December 1, 2025, the State Board

of Dental Examiners shall adopt the rules required by Section

258.0531, Occupations Code, as added by this Act.

SECTION 3. This Act takes effect September 1, 2025.

* * * * *

Back to the full text